Diaceutics to List on London Stock Exchange
Summary
Diaceutics has conditionally raised £17M by way of a placing of 22,368,427 ordinary shares of 76p each through its nominated adviser and broker, Cenkos Securities plc. As part of this data collection, it has accumulated a global proprietary database of individual laboratories’ capabilities across the industry. Using its expertise and its data set, the company is able to assist pharmaceutical clients to improve the development, and delivery, of diagnostic testing. In 2018, the company had an average of 65 full-time employees in 17 countries and achieved compound annual revenue growth in sales of over 50% in the past two years. – £1.2 million to strengthen the company’s balance sheet which is expected to support future proposals submitted to pharma clients.
Classifications
AskAI Classifications
LabelsLinked Companies
